[Lipoprotein (a) in physiological states and kidney diseases].
The present paper is a concise summary of contemporary knowledge of lipoprotein(a). Increased lipoprotein(a) concentration is an independent risk factor for atherogenesis. The treatment of choice of increased lipoprotein(a) concentration is causal--for example treatment of the nephrotic syndrome or renal transplantation. If this is not amenable, careful monitoring and elimination of additional risk factors of atherogenesis are mandatory.